Íñigo Ojanguren

1.1k total citations
66 papers, 370 citations indexed

About

Íñigo Ojanguren is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Íñigo Ojanguren has authored 66 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 28 papers in Physiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Íñigo Ojanguren's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Asthma and respiratory diseases (23 papers) and Occupational exposure and asthma (10 papers). Íñigo Ojanguren is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Asthma and respiratory diseases (23 papers) and Occupational exposure and asthma (10 papers). Íñigo Ojanguren collaborates with scholars based in Spain, United Kingdom and United States. Íñigo Ojanguren's co-authors include María Jesús Cruz, Xavier Muñoz, Ferrán Morell, Ana Villar, María Antonia Ramón, Vicente Plaza, Francisco Javier González‐Barcala, Susana Gómez‐Ollés, Diego Varona Porres and Marc Miravitlles and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Íñigo Ojanguren

62 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Íñigo Ojanguren Spain 11 245 130 115 53 26 66 370
Susana Gómez‐Ollés Spain 13 138 0.6× 105 0.8× 78 0.7× 92 1.7× 77 3.0× 46 379
Claudia Flexeder Germany 11 173 0.7× 38 0.3× 146 1.3× 31 0.6× 18 0.7× 19 317
Kentaro Wakamatsu Japan 12 301 1.2× 86 0.7× 112 1.0× 21 0.4× 80 3.1× 36 460
S.R. Del Giacco Italy 8 286 1.2× 42 0.3× 345 3.0× 15 0.3× 22 0.8× 16 503
Q T Pham France 12 236 1.0× 126 1.0× 81 0.7× 179 3.4× 58 2.2× 31 518
Daniel A. Searing United States 8 179 0.7× 45 0.3× 411 3.6× 39 0.7× 33 1.3× 11 652
David Soussan France 7 348 1.4× 51 0.4× 534 4.6× 55 1.0× 28 1.1× 9 707
Tari Haahtela Finland 9 439 1.8× 36 0.3× 495 4.3× 15 0.3× 37 1.4× 10 571
Antonella Di Franco Italy 16 384 1.6× 62 0.5× 454 3.9× 119 2.2× 37 1.4× 26 664
Joanna Miłkowska-Dymanowska Poland 11 192 0.8× 20 0.2× 85 0.7× 12 0.2× 20 0.8× 41 334

Countries citing papers authored by Íñigo Ojanguren

Since Specialization
Citations

This map shows the geographic impact of Íñigo Ojanguren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Íñigo Ojanguren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Íñigo Ojanguren more than expected).

Fields of papers citing papers by Íñigo Ojanguren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Íñigo Ojanguren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Íñigo Ojanguren. The network helps show where Íñigo Ojanguren may publish in the future.

Co-authorship network of co-authors of Íñigo Ojanguren

This figure shows the co-authorship network connecting the top 25 collaborators of Íñigo Ojanguren. A scholar is included among the top collaborators of Íñigo Ojanguren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Íñigo Ojanguren. Íñigo Ojanguren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muñoz, Xavier, et al.. (2024). Increased TGFβ1, VEGF and IFN-γ in the Sputum of Severe Asthma Patients With Bronchiectasis. Archivos de Bronconeumología. 60(11). 682–689. 2 indexed citations
2.
Plaza, Vicente, Juan Antonio Trigueros, Juan A. Carretero, et al.. (2024). Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force. Journal of Investigational Allergology and Clinical Immunology. 34(4). 257–260.
3.
Cruz, María Jesús, et al.. (2023). The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy. Archivos de Bronconeumología. 59(11). 736–742. 1 indexed citations
4.
Fuente, Enrique Gómez de la, et al.. (2023). Addressing the unmet needs in patients with type 2 inflammatory diseases: when quality of life can make a difference. SHILAP Revista de lepidopterología. 4. 1296894–1296894. 4 indexed citations
5.
Cruz, María Jesús, et al.. (2023). Immunopathological Mechanisms of Bird-Related Hypersensitivity Pneumonitis. International Journal of Molecular Sciences. 24(3). 2884–2884. 5 indexed citations
6.
Barrecheguren, Míriam, Mónica Monteagudo, Marc Miravitlles, et al.. (2022). Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain. npj Primary Care Respiratory Medicine. 32(1). 11–11. 3 indexed citations
7.
Ojanguren, Íñigo, et al.. (2022). Influence of the environment on the characteristics of asthma. Scientific Reports. 12(1). 20522–20522. 1 indexed citations
8.
Plaza, Vicente, Carolina Cisneros, Javier Domínguez‐Ortega, et al.. (2021). The Importance of Small Airway Dysfunction in Asthma: The GEMA-FORUM III Task Force. Journal of Investigational Allergology and Clinical Immunology. 31(5). 433–436. 2 indexed citations
9.
Morell, Ferrán, Ana Villar, Íñigo Ojanguren, et al.. (2021). Hypersensitivity Pneumonitis and (Idiopathic) Pulmonary Fibrosis Due to Feather Duvets and Pillows. Archivos de Bronconeumología. 57(2). 87–93. 3 indexed citations
10.
Cruz, María Jesús, et al.. (2021). Risk factors for the development of bronchiectasis in patients with asthma. Scientific Reports. 11(1). 22820–22820. 17 indexed citations
11.
Muñoz, Xavier, et al.. (2020). Is asthma a risk factor for COVID-19? Are phenotypes important?. ERJ Open Research. 7(1). 216–2020. 12 indexed citations
12.
Ojanguren, Íñigo, et al.. (2020). Rural and Urban Asthma: Are they Different?. 1310–1310.
13.
Ojanguren, Íñigo, et al.. (2019). Neumotórax iatrogénico tras malposición de sonda nasogástrica. Archivos de Bronconeumología. 56(2). 117–117. 1 indexed citations
14.
Vanfleteren, Lowie E.G.W., Íñigo Ojanguren, Claire M. Nolan, et al.. (2019). European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical Assembly. ERJ Open Research. 5(1). 176–2018. 1 indexed citations
15.
Ojanguren, Íñigo, Ferrán Morell, María Antonia Ramón, et al.. (2018). Long‐term outcomes in chronic hypersensitivity pneumonitis. Allergy. 74(5). 944–952. 63 indexed citations
16.
Ojanguren, Íñigo, et al.. (2018). Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study.. PA2961–PA2961. 1 indexed citations
17.
Cruz, María Jesús, et al.. (2017). Effect of anti‐IgE in occupational asthma caused by exposure to low molecular weight agents. Allergy. 72(11). 1720–1727. 6 indexed citations
18.
Ojanguren, Íñigo. (2016). Diagnosis and follow up of chronic hypersensitivity pneumonitis: utility of non-invasive measurement of airway inflammation /. Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona). 1 indexed citations
19.
Ojanguren, Íñigo. (1998). Novak, J. D. , Conocimiento y aprendizaje.Los mapas conceptuales como herramientas facilitadoras para escuelas y empresas, alianza, Madrid, 1998. 40–42. 3 indexed citations
20.
Olivé, Alejandro, et al.. (1996). BONE BACILLARY ANGIOMATOSIS IN AN HIV-INFECTED PATIENT. Lara D. Veeken. 35(9). 901–904. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026